StemCells Inc. STEM reported a wider loss for the fourth quarter on Monday.
The Newark, California-based company posted a quarterly net loss of $10,249,000, or $(0.15) per share, versus a year-ago net loss of $6,963,000, or $(0.13) per share. Excluding certain items, StemCells reported a non-GAAP loss of $(0.14) per share, compared to a loss of $(0.16) per share.
Its total revenue from continuing operations climbed to $883,000, from $45,000 in the year-ago period. However, analysts were expecting a loss of $0.12 per share on revenue of $220.00 thousand.
Its total operating expenses from continuing operations widened to $10,612,000 in the fourth quarter, from $9,341,000.
At December 31, 2014, StemCells had $24,988,000 in cash and cash equivalents, an 18% drop versus December 31, 2013.
StemCells shares rose 0.81% to $1.25 in the after-hours trading session.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in